Maxim Integrated Products (MXIM) 10-Q 25 Apr 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document	9 Months Ended
	Mar. 29, 2014	Apr. 17, 2014
DEI [Abstract]	'	'
Entity Registrant Name	'MAXIM INTEGRATED PRODUCTS INC	'
Entity Central Index Key	'0000743316	'
Trading Symbol	'MXIM	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	29-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Current Fiscal Year End Date	'--06-28	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	282,713,828

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 29, 2014	Jun. 29, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$1,231,248	$1,174,986
Short-term Investments	0	25,060
Total cash, cash equivalents and short-term investments	1,231,248	1,200,046
Accounts receivable, net	304,128	285,438
Inventories	290,518	275,640
Deferred tax assets	74,038	82,173
Other current assets	79,346	96,609
Total current assets	1,979,278	1,939,906
Property, plant and equipment, net	1,355,268	1,373,124
Intangible assets, net	384,167	157,146
Goodwill	597,676	422,004
Other assets	38,176	43,730
TOTAL ASSETS	4,354,565	3,935,910
Current liabilities:	'	'
Accounts payable	94,315	105,322
Income taxes payable	20,720	22,437
Accrued salary and related expenses	168,336	187,970
Accrued expenses	81,232	60,592
Long-term Debt, Current Maturities	2,526	2,015
Deferred income on shipments to distributors	24,259	26,557
Total current liabilities	391,388	404,893
Long term debt	1,000,871	503,573
Income taxes payable	352,294	282,697
Deferred tax liabilities	171,431	206,855
Other liabilities	37,977	29,894
Total liabilities	1,953,961	1,427,912
Commitments and contingencies (Note 11)	'	'
Stockholders' equity:	'	'
Common stock and capital in excess of par value	283	288
Retained earnings	2,412,627	2,523,457
Accumulated other comprehensive loss	-12,306	-15,747
Total stockholders' equity	2,400,604	2,507,998
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	$4,354,565	$3,935,910

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Income Statement [Abstract]	'	'	'	'
Net revenues	$605,681	$604,884	$1,811,196	$1,833,265
Cost of goods sold	265,744	228,782	795,391	708,097
Gross margin	339,937	376,102	1,015,805	1,125,168
Operating expenses:	'	'	'	'
Research and development	141,493	134,138	414,366	402,810
Selling, general and administrative	80,680	81,954	241,581	242,199
Operating Expenses, Amortization	4,863	3,903	13,267	11,855
Impairment of Long-Lived Assets to be Disposed of	0	0	5,197	24,929
Severance and restructuring expenses	3,338	151	19,112	2,387
Business Combination, Acquisition Related Costs	-88	0	6,983	0
Other operating (income) expenses, net	2,913	1,678	9,558	3,759
Total operating expenses	233,199	221,824	710,064	687,939
Operating income	106,738	154,278	305,741	437,229
Interest and other expense, net	5,174	-2,669	-4,122	-11,209
Income before provision for income taxes	111,912	151,609	301,619	426,020
Provision for income taxes	-10,632	22,824	31,602	92,725
Income (Loss) from Continuing Operations Attributable to Parent	122,544	128,785	270,017	333,295
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	0	2,603	0	2,603
Net income	$122,544	$131,388	$270,017	$335,898
Earnings per share:	'	'	'	'
Income (Loss) from Continuing Operations, Per Basic Share	$0.43	$0.44	$0.95	$1.14
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	$0	$0.01	$0	$0.01
Basic (per share)	$0.43	$0.45	$0.95	$1.15
Income (Loss) from Continuing Operations, Per Diluted Share	$0.42	$0.43	$0.93	$1.11
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	$0	$0.01	$0	$0.01
Diluted (per share)	$0.42	$0.44	$0.93	$1.12
Shares used in the calculation of earnings per share:	'	'	'	'
Basic (in shares)	282,627	292,888	283,315	292,048
Diluted (in shares)	288,575	300,082	289,122	298,821
Dividends paid per share	$0.26	$0.24	$0.78	$0.72

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Statements of Income and Comprehensive Income [Abstract]	'	'	'	'
Net income	$122,544	$131,388	$270,017	$335,898
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax	0	-64	-23	-166
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	313	-631	870	-248
Unrealized gains (losses) on post-retirement benefits, net of tax benefit (expense)	285	405	852	1,659
Tax effect of the unrealized exchange gain (loss) on long-term intercompany receivables	-335	-1,885	1,742	-3,433
Other Comprehensive Income (Loss), Net of Tax	263	-2,175	3,441	-2,188
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$122,807	$129,213	$273,458	$333,710

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
Fair Value of Assets Acquired	$0	$15,290
Cash flows from operating activities:	'	'
Net income	270,017	335,898
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Stock-based compensation	63,666	64,955
Depreciation and amortization	180,202	155,945
Deferred taxes	-22,658	28,185
Research and Development in Process	2,580	2,800
Loss on sale of property, plant and equipment	1,119	-2,536
Tax benefit (shortfall) related to stock-based compensation plans	-1,010	7,839
Impairment of Long-Lived Assets to be Disposed of	5,197	24,929
Gain (Loss) on Sale of Equity Investments	3,723	0
Excess tax benefit related to stock-based compensation	-9,295	-16,131
Cash Provided by (Used in) Operating Activities, Discontinued Operations	0	-3,285
Changes in assets and liabilities:	'	'
Accounts receivable	5,040	17,415
Inventories	19,446	-27,588
Other current assets and income tax refund receivable	18,978	-18,401
Accounts payable	-16,458	-25,549
Income taxes payable	44,639	57,038
Deferred income on shipments to distributors	-2,298	-429
All other accrued liabilities	-20,865	2,450
Net cash provided by operating activities	542,023	603,535
Cash flows from investing activities:	'	'
Purchase of property, plant and equipment	-108,869	-167,750
Proceeds from sale of property, plant, and equipment	3,666	14,658
Payments to Acquire Businesses, Net of Cash Acquired	-459,256	0
Proceeds from Sale and Maturity of Available-for-sale Securities	27,000	50,000
Net cash used in investing activities	-537,459	-103,092
Cash flows from financing activities:	'	'
Excess tax benefit related to stock-based compensation	9,295	16,131
Contingent consideration paid	-4,705	-7,476
Repayment of notes payable	-2,278	-1,201
Proceeds from Issuance of Long-term Debt	497,895	491,145
Debt Issuance Cost	-3,431	0
Net issuance of restricted stock units	-22,462	-21,586
Proceeds from stock options exercised	43,407	65,293
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options	19,096	16,768
Repurchase of common stock	-264,570	-181,914
Dividends paid	-220,549	-210,683
Net cash used in financing activities	51,698	166,477
Net decrease in cash and cash equivalents	56,262	666,920
Cash and cash equivalents:	'	'
Beginning of period	1,174,986	881,060
End of period	1,231,248	1,547,980
Supplemental disclosures of cash flow information:	'	'
Cash paid (refunded), net during the period for income taxes	-11,185	13,115
Cash paid for interest	16,801	5,377
Noncash investing and financing activities:	'	'
Accounts payable related to property, plant, and equipment purchases	11,916	19,171
Fair Value of Assets Acquired	$0	$15,290

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Mar. 29, 2014
Basis of Presentation [Abstract]	'
Basis of Presentation [Text Block]	'
	BASIS OF PRESENTATION
	The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair presentation have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the nine months ended March 29, 2014 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K for the fiscal year ended June 29, 2013. The Condensed Consolidated Financial Statements included in this Quarterly Report include the financial results of Volterra Semiconductor Corporation (“Volterra”) prospectively from the date of acquisition. Refer to Note 13: “Acquisitions” of these Notes to Condensed Consolidated Interim Financial Statements for further discussion in relation to Volterra.
	The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal years 2014 and 2013 are 52-week fiscal years.

Recently_Issued_Accounting_Pro

Recently Issued Accounting Pronouncements	9 Months Ended
	Mar. 29, 2014
Recently Issued Accounting Pronouncements [Abstract]	'
Recently Issued Accounting Pronouncements [Text Block]	'
	RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
	(i) New Accounting Updates Recently Adopted
	In the first quarter of fiscal year 2014, the Company adopted Accounting Standards Update (“ASU”) No. 2013-02, Comprehensive Income (Topic 220)- Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income that requires reclassification adjustments from other comprehensive income to be presented either in the financial statements or in the notes to the financial statements. The adoption of this amended standard resulted in the presentation of the reclassification adjustments in the Notes to the Company's Condensed Consolidated Financial Statements. Refer to Note 9: “Comprehensive income” for the disclosure requirements provided.
	(ii) Recent Accounting Updates Not Yet Effective
	In July 2013, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2013-11, Income Taxes (Topic 740)-Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). ASU 2013-11 requires certain unrecognized tax benefits to be presented as reductions to deferred tax assets instead of liabilities on the Condensed Consolidated Balance Sheets. The Company will be required to adopt ASU 2013-11 on a prospective basis in the first quarter of fiscal year 2015; however, early adoption is permitted, as is a retrospective application. The Company is currently evaluating the impact of this new standard on its Condensed Consolidated Balance Sheets.
	In April 2014, the FASB issued ASU No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. ASU 2014-08 redefines discontinued operations as disposals representing a strategic shift in operations and having a major effect on the organization’s operations and financial results. The Company is currently evaluating the potential impact of this standard on its financial statements. The Company will be required to adopt ASU 2014-08 on a prospective basis starting in fiscal year 2016.

Balance_Sheet_Components

Balance Sheet Components	9 Months Ended
	Mar. 29, 2014
Balance Sheet Related Disclosures [Abstract]	'
Balance Sheet Components [Text Block]	'
	BALANCE SHEET COMPONENTS
	Accounts receivable, net consists of:
		March 29,			June 29,
		2014			2013
	Accounts Receivable:	(in thousands)
	Accounts receivable	$	320,363		$	299,083
	Returns and allowances	(16,235		)	(13,645		)
		$	304,128		$	285,438
	Inventories consist of:
		March 29,			June 29,
		2014			2013
	Inventories:	(in thousands)
	Raw materials	$	13,906		$	14,055
	Work-in-process	186,249			184,511
	Finished goods	90,363			77,074
		$	290,518		$	275,640
	Property, plant and equipment, net consists of:
		March 29,			June 29,
		2014			2013
	Property, plant and equipment:	(in thousands)
	Land	$	62,093		$	62,093
	Buildings and building improvements	376,112			364,037
	Machinery and equipment	2,146,411			2,099,301
		2,584,616			2,525,431
	Less: accumulated depreciation and amortization	(1,229,348		)	(1,152,307		)
		$	1,355,268		$	1,373,124

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Mar. 29, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements [Text Block]	'
	FAIR VALUE MEASUREMENTS
	The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows:
	Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.
	The Company’s Level 1 assets consist of money market funds.
	Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
	The Company’s Level 2 assets and liabilities consist of certificates of deposit, government agency securities and foreign currency forward contracts.
	Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	The Company’s Level 3 consists of contingent consideration liability related to certain prior years’ acquisitions
	Assets and liabilities measured at fair value on a recurring basis were as follows:
		As of March 29, 2014												As of June 29, 2013
		Fair Value										Total		Fair Value						Total
		Measurements Using										Balance		Measurements Using						Balance
		Level 1				Level 2				Level 3				Level 1		Level 2		Level 3
		(in thousands)
	Assets
	Money market funds (1)	$	744,979			$	—			$	—	$	744,979	$	402,513	$	—	$	—	$	402,513
	Certificates of deposit (1)	—				—				—		—		—		77		—		77
	Government agency securities (2)	—				—				—		—		—		25,060		—		25,060
	Foreign currency forward contracts (3)	—				157				—		157		—		187		—		187
	Total Assets	$	744,979			$	157			$	—	$	745,136	$	402,513	$	25,324	$	—	$	427,837
	Liabilities
	Foreign currency forward contracts (4)	$	—			$	399			$	—	$	399	$	—	$	1,419	$	—	$	1,419
	Contingent Consideration (4)	—				—				4,358		4,358		—		—		8,577		8,577
	Total Liabilities	$	—			$	399			$	4,358	$	4,757	$	—	$	1,419	$	8,577	$	9,996
	(1) Included in Cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets.
	(2) Included in Short-term investments in the accompanying Condensed Consolidated Balance Sheets.
	(3) Included in Other current assets in the accompanying Condensed Consolidated Balance Sheets.
	(4) Included in Accrued expenses in the accompanying Condensed Consolidated Balance Sheets.
	The tables below present reconciliations for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended March 29, 2014 and March 30, 2013:
	Fair Value Measured and Recorded Using Significant Unobservable Inputs (Level 3)
			March 29,				March 30,
			2014				2013
	Contingent Consideration		(in thousands)
	Beginning balance		$	8,577			$	17,737
	Total gains or losses (realized and unrealized):
	Included in earnings		1,632				3,226
	Payments		(5,851		)		(7,476		)
	Ending balance		$	4,358			$	13,487
	Changes in unrealized losses (gains) included in earnings related to liabilities still held as of period end		$	1,632			$	3,226
	The valuation of contingent consideration is based on a probability weighted earnout model which relies primarily on estimates of milestone achievements and discount rates applicable for the period expected payout. The most significant unobservable input used in the determination of estimated fair value of contingent consideration is the estimates on the likelihood of milestone achievements, which directly correlates to the fair value recognized in the Condensed Consolidated Balance Sheets.
	The fair value of this liability is estimated quarterly by management based on inputs received from the Company’s engineering and finance personnel. The determination of the milestone achievement is performed by the Company’s business units and reviewed by the accounting department. Potential valuation adjustments are made as the progress toward achieving milestones becomes determinable, with the impact of such adjustments being recorded to Other operating expenses (income), net.
	During the nine months ended March 29, 2014 and the year ended June 29, 2013, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.
	There were no assets or liabilities measured at fair value on a non-recurring basis as of March 29, 2014 and June 29, 2013.

Financial_Instruments

Financial Instruments	9 Months Ended
	Mar. 29, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Financial Instruments [Text Block]	'
	FINANCIAL INSTRUMENTS
	Short-term investments
	Fair values were as follows:
		March 29, 2014										June 29, 2013
		Amortized Cost			Gross Unrealized Gain			Gross Unrealized Loss		Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value
		(in thousands)
	Available-for-sale investments
	Government agency securities	$	—		$	—		$	—	$	—	$	25,024	$	36	$	—	$	25,060
	Total available-for-sale investments	$	—		$	—		$	—	$	—	$	25,024	$	36	$	—	$	25,060
	In the nine months ended March 29, 2014 and the year ended June 29, 2013, the Company did not recognize any impairment charges on short-term investments.
	Derivative instruments and hedging activities
	The Company generates less than 5% of its revenues in various global markets based on orders obtained in non-U.S. currencies, primarily the Japanese Yen, the Euro and the British Pound. The Company incurs expenditures denominated in non-U.S. currencies, including the Philippine Peso and Thai Baht associated with the Company’s manufacturing activities in the Philippines and Thailand, respectively, and expenditures for sales offices and research and development activities undertaken outside of the U.S.
	The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.
	Derivatives designated as cash flow hedging instruments
	The Company designates certain forward contracts as hedging instruments pursuant to ASC 815 Derivatives and Hedging. As of March 29, 2014 and June 29, 2013, respectively, the notional amounts of the forward contracts we held to purchase U.S. Dollars in exchange for other international currencies were $52.9 million and $53.8 million, respectively, and the notional amounts of forward contracts we held to sell U.S. Dollars in exchange for other international currencies were $1.4 million and $3.2 million, respectively.
	Derivatives not designated as hedging instruments
	As of March 29, 2014 and June 29, 2013, respectively, the notional amounts of the forward contracts we held to purchase U.S. Dollars in exchange for other international currencies were $15.9 million and $15.0 million, respectively, and the notional amounts of forward contracts we held to sell U.S. Dollars in exchange for other international currencies were $31.1 million and $36.5 million, respectively. The fair values of our outstanding foreign currency forward contracts and amounts included in the condensed consolidated statement of income were not material for nine months ended March 29, 2014 and year ended June 29, 2013.
	Long-term debt
	The following table summarizes the Company’s long-term debt:
		March 29,			June 29,
		2014			2013
		(in thousands)
	3.375% fixed rate notes due March 2023	$	500,000		$	500,000
	2.5% fixed rate notes due November 2018	500,000			—
	Notes denominated in Euro
	Amortizing floating rate notes (EURIBOR plus 1.5%) due up to June 2014	2,526			4,804
	Term fixed rate notes (2.0%-2.5%) due up to September 2015	871			784
	Total	1,003,397			505,588
	Less: Current portion	(2,526		)	(2,015		)
	Total long-term debt	$	1,000,871		$	503,573
	On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million, after issuing at a discount and deducting paid expenses, and are included in the financing activities in the Condensed Consolidated Statements of Cash Flows.
	On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5%. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million, after issuing at a discount and deducting paid expenses, and are included in the financing activities in the Condensed Consolidated Statements of Cash Flows.
	The 2018 Notes and the 2023 Notes are governed by a base indenture, dated June 10, 2010, and supplemental indentures, dated March 18, 2013 with respect to the 2023 Notes and November 21, 2013 with respect to the 2018 Notes, between the Company and Wells Fargo Bank, National Association, as trustee.
	The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net over the life of the notes. Interest expense associated with the notes was $7.4 million and $3.8 million during the three months ended March 29, 2014 and March 30, 2013, respectively. Interest expense associated with the notes was $17.3 million and $9.6 million during the nine months ended March 29, 2014 and March 30, 2013, respectively. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income.
	The estimated fair value of the Company’s debt was approximately $983 million as of March 29, 2014. The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.
	Other Financial Instruments
	For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Mar. 29, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-Based Compensation [Text Block]	'
	STOCK-BASED COMPENSATION
	The following table shows total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 29, 2014 and March 30, 2013:
		Three Months Ended
		March 29, 2014												March 30, 2013
		Stock Options			Restricted Stock Units				Employee Stock Purchase Plan			Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
		(in thousands)
	Cost of goods sold	$	451		$	2,108			$	594		$	3,153	$	337	$	2,120	$	598	$	3,055
	Research and development	2,124			7,917				1,623			11,664		1,440		7,116		1,480		10,036
	Selling, general and administrative	1,391			5,186				663			7,240		1,157		4,764		601		6,522
	Pre-tax stock-based compensation expense	$	3,966		$	15,211			$	2,880		$	22,057	$	2,934	$	14,000	$	2,679	$	19,613
	Less: income tax effect											3,400								2,847
	Net stock-based compensation expense											$	18,657							$	16,766
		Nine Months Ended
		March 29, 2014												March 30, 2013
		Stock Options			Restricted Stock Units				Employee Stock Purchase Plan			Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
		(in thousands)
	Cost of goods sold	$	1,238		$	6,421			$	1,602		$	9,261	$	1,212	$	6,863	$	1,651	$	9,726
	Research and development	6,576			23,085				4,098			33,759		5,557		24,727		4,215		34,499
	Selling, general and administrative	4,131			14,709				1,806			20,646		3,998		15,035		1,697		20,730
	Pre-tax stock-based compensation expense	$	11,945		$	44,215			$	7,506		$	63,666	$	10,767	$	46,625	$	7,563	$	64,955
	Less: income tax effect											9,878								11,617
	Net stock-based compensation expense											$	53,788							$	53,338
	Volterra Substitute Awards
	In connection with the Volterra acquisition, the Company issued substitute awards to certain Volterra employees. Substitute awards included options to purchase approximately 673,185 shares of Maxim Integrated's common stock at a weighted-average grant date fair value of approximately $10.56 and a weighted-average exercise price of approximately $22.26 per share and also issued approximately 418,955 restricted stock units with a weighted-average grant date fair value of $29.53. The terms of these awards were substantially the same as those granted by Volterra. The intrinsic value of these awards was substantially the same immediately prior to and after the substitution as of October 1, 2013.
	Stock Options
	The fair value of options granted to employees under the Company’s Amended and Restated 1996 Stock Incentive Plan is estimated on the date of grant using the Black-Scholes option valuation model.
	Expected volatilities are based on the historical volatilities from the Company’s traded common stock over a period equal to the expected term. The Company is utilizing the simplified method to estimate expected holding periods. The risk-free interest rate is based on the U.S. Treasury yield. The Company determines the dividend yield by dividing the annualized dividends per share by the prior quarter’s average stock price. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.
	The fair value of options granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions:
		Stock Options (1)
		Three Months Ended					Nine Months Ended
		March 29,		March 30,			March 29,			March 30,
		2014		2013			2014			2013
	Expected holding period (in years)	4.9		4.9			5.3			5.3
	Risk-free interest rate	1.6	%	0.8	%		1.4	%		0.7	%
	Expected stock price volatility	30.2	%	37.5	%		34.8	%		37.8	%
	Dividend yield	3.6	%	3.4	%		3.2	%		3.3	%
	(1) Table excludes impact from assumptions used in valuing the Volterra substitute options granted on October 1, 2013 based on an expected holding period of 3.8 years, risk-free interest rate of 1.0%, expected stock price volatility of 27.5% and dividend yield of 3.4%.
	The weighted-average fair value of stock options granted was $5.55 and $7.39 per share for the three months ended March 29, 2014 and March 30, 2013, respectively. The weighted-average fair value of stock options granted was $7.39 and $6.69 per share for the nine months ended March 29, 2014 and March 30, 2013, respectively.
	The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 29, 2014 and their activity for the nine months ended March 29, 2014:
		Number of		Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (in Years)		Aggregate Intrinsic Value (1)
		Shares
	Balance at June 29, 2013	20,081,339		$	26
	Options Granted	2,882,740		27.17
	Volterra substitute options granted	673,185		22.26
	Options Exercised	(2,267,719	)	18.07
	Options Cancelled	(3,042,128	)	32.25
	Balance at March 29, 2014	18,327,417		$	26.04			3.6		$	148,116,516
	Exercisable, March 29, 2014	8,592,118		$	27.62			1.9		$	69,970,388
	Vested and expected to vest, March 29, 2014	17,245,995		$	26.01			3.5		$	141,248,804
	-1	Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 28, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 29, 2014.
	As of March 29, 2014, there was $40.7 million of total unrecognized stock compensation cost related to 9.7 million unvested stock options, which is expected to be recognized over a weighted average period of approximately 2.8 years.
	As of March 30, 2013, there was $35.3 million of total unrecognized stock compensation cost related to 10.2 million unvested stock options, which is expected to be recognized over a weighted average period of approximately 2.8 years.
	Restricted Stock Units
	The fair value of Restricted Stock Units (“RSUs”) under the Company’s Amended and Restated 1996 Stock Incentive Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.
	The weighted-average fair value of RSUs granted was $29.57 and $29.48 per share for the three months ended March 29, 2014 and March 30, 2013, respectively. The weighted-average fair value of RSUs granted was $26.31 and $25.08 per share for the nine months ended March 29, 2014 and March 30, 2013, respectively.
	The following table summarizes outstanding and expected to vest RSUs as of March 29, 2014 and their activity during the nine months ended March 29, 2014:
		Number of		Weighted Average		Aggregate Intrinsic
		Shares		Remaining		Value (1)
				Contractual Term
				(in Years)
	Balance at June 29, 2013	7,965,532
	Restricted stock units granted	3,387,079
	Volterra substitute restricted stock units granted	418,955
Restricted stock units released	(2,141,883	)
Restricted stock units cancelled	(903,922	)
Balance at March 29, 2014	8,725,761		2.7		$	284,624,813
Outstanding and expected to vest, March 29, 2014	7,626,649		2.7		$	249,086,361
-1	Aggregate intrinsic value for RSUs represents the closing price per share of the Company’s common stock on March 28, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 29, 2014.
The Company withheld shares totaling $8.4 million and $22.5 million in value as a result of employee withholding taxes based on the value of the RSUs on their vesting date for the three and nine months ended March 29, 2014, respectively. The total payments for the employees’ tax obligations to the taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows.
As of March 29, 2014, there was $146.3 million of unrecognized compensation expense related to 8.7 million unvested RSUs, which is expected to be recognized over a weighted average period of approximately 2.7 years.
As of March 30, 2013, there was $127.6 million of unrecognized compensation expense related to 8.7 million unvested RSUs, which is expected to be recognized over a weighted average period of approximately 2.7 years.
Employee Stock Purchase Plan
The fair value of rights to acquire common stock under the Company’s 2008 Employee Stock Purchase Plan (the “ESPP”) is estimated on the date of grant using the Black-Scholes option valuation model.
The fair value of ESPP granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following weighted-average assumptions:
	ESPP
	Three Months Ended					Nine Months Ended
	March 29,		March 30,			March 29,			March 30,
	2014		2013			2014			2013
Expected holding period (in years)	0.5		0.5			0.5			0.5
Risk-free interest rate	0.1	%	0.1	%		0.1	%		0.1	%
Expected stock price volatility	21.7	%	26.1	%		21.7	%		26.1	%
Dividend yield	3.7	%	3.6	%		3.7	%		3.6	%
As of March 29, 2014, there was $4.9 million of unrecognized compensation expense related to the ESPP.

Earnings_Per_Share

Earnings Per Share	9 Months Ended
	Mar. 29, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	EARNINGS PER SHARE
	Basic earnings per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs. Diluted earnings per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and assumed issuance of common stock under the employee stock purchase plans using the treasury stock method.
	The following table sets forth the computation of basic and diluted earnings per share:
		Three Months Ended				Nine Months Ended
		March 29,		March 30,		March 29,		March 30,
		2014		2013		2014		2013
		(in thousands, except per share data)
	Numerator for basic earnings per share and diluted earnings per share
	Net income	$	122,544	$	131,388	$	270,017	$	335,898
	Denominator for basic earnings per share	282,627		292,888		283,315		292,048
	Effect of dilutive securities:
	Stock options, ESPP and RSUs	5,948		7,194		5,807		6,773
	Denominator for diluted earnings per share	288,575		300,082		289,122		298,821
	Earnings per share: basic
	From continuing operations	$	0.43	$	0.44	$	0.95	$	1.14
	From discontinued operations	—		0.01		—		0.01
	Basic	$	0.43	$	0.45	$	0.95	$	1.15
	Earnings per share: diluted
	From continuing operations	$	0.42	$	0.43	$	0.93	$	1.11
	From discontinued operations	—		0.01		—		0.01
	Diluted	$	0.42	$	0.44	$	0.93	$	1.12
	Approximately 9.8 million and 9.0 million stock options were excluded from the calculation of diluted earnings per share for the three months ended March 29, 2014 and March 30, 2013, respectively. Approximately 9.8 million and 10.6 million stock options were excluded from the calculation of diluted earnings per share for the nine months ended March 29, 2014 and March 30, 2013, respectively. These options were excluded because they were determined to be antidilutive. However, such options could be dilutive in the future and, under those circumstances, would be included in the calculation of diluted earnings per share.

Segment_Information

Segment Information	9 Months Ended
	Mar. 29, 2014
Segment Reporting [Abstract]	'
Segment Information [Text Block]	'
	SEGMENT INFORMATION
	The Company operates and tracks its results in one reportable segment. The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. The Chief Executive Officer has been identified as the Chief Operating Decision Maker as defined by ASC No. 280, Segment Reporting (“ASC 280”).
	The Company has three operating segments that aggregate into one reportable segment. Under ASC 280, two or more operating segments may be aggregated into a single operating segment for financial reporting purposes if aggregation is consistent with the objective and basic principles of ASC 280, if the segments have similar economic characteristics, and if the segments are similar in each of the following areas:
	•	the nature of products and services;
	•	the nature of the production processes;
	•	the type or class of customer for their products and services; and
	•	the methods used to distribute their products or provide their services.
	The Company meets each of the aggregation criteria for the following reasons:
	•	the sale of analog and mixed signal integrated circuits is the primary source of revenue for each of the Company’s three operating segments;
	•	the integrated circuits sold by each of the Company’s operating segments are manufactured using similar semiconductor manufacturing processes;
	•	the integrated circuits marketed by each of the Company’s operating segments are sold to the same types of customers; and
	•	all of the Company’s integrated circuits are sold through a centralized sales force and common wholesale distributors.
	All of the Company’s operating segments share similar long-term financial performance as they have similar economic characteristics, including gross margins. The causes for variation among the Company’s operating segments are the same and include factors such as (i) life cycle and price and cost fluctuations, (ii) number of competitors, (iii) product differentiation and (iv) size of market opportunity. Additionally, each operating segment is subject to the overall cyclical nature of the semiconductor industry. The number and composition of employees and the amounts and types of tools and materials required are similar for each operating segment. Finally, even though the Company periodically reorganizes the Company’s operating segments based upon changes in customers, end-markets or products, acquisitions, long-term growth strategies, and the experience and bandwidth of the senior executives in charge, the common financial goals for each operating segment remain constant.
	Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each reporting period.
	Net revenues from unaffiliated customers by geographic region were as follows:
			Three Months Ended					Nine Months Ended
			March 29,			March 30,		March 29,		March 30,
			2014			2013		2014		2013
			(in thousands)
	United States		$	68,944		$	63,784	$	241,082	$	185,765
	China		240,677			225,808		745,886		767,192
	Korea		33,217			73,362		101,979		194,357
	Rest of Asia		160,703			151,231		444,270		425,904
	Europe		84,005			75,734		230,032		213,582
	Rest of World		18,135			14,965		47,947		46,465
			$	605,681		$	604,884	$	1,811,196	$	1,833,265
	Net long-lived assets by geographic region were as follows:
		March 29,			June 29,
		2014			2013
		(in thousands)
	United States	$	1,057,881		$	1,058,579
	Philippines	175,636			183,671
	Rest of World	121,751			130,874
		$	1,355,268		$	1,373,124

Comprehensive_Income

Comprehensive Income	9 Months Ended
	Mar. 29, 2014
Statement of Comprehensive Income [Abstract]	'
Comprehensive Income [Text Block]	'
	COMPREHENSIVE INCOME
	The changes in accumulated other comprehensive loss by component and related tax effects in the nine months ended March 29, 2014 were as follows:
	(in thousands)	Unrealized gain (loss) on intercompany receivables			Unrealized gain (loss) on post-retirement benefits			Cumulative translation adjustment			Unrealized gain (loss) on cash flow hedges			Unrealized gain (loss) on available-for-sale securities			Total
	29-Jun-13	$	(7,401	)	$	(5,838	)	$	(1,527	)	$	(1,004	)	$	23		$	(15,747	)
	Other comprehensive income (loss) before reclassifications	—			—			—			(465		)	(36		)	(501		)
	Amounts reclassified out of accumulated other comprehensive income (loss)	—			1,076			—			1,525			—			2,601
	Tax effects	1,742			(224		)	—			(190		)	13			1,341
	Other comprehensive income (loss)	1,742			852			—			870			(23		)	3,441
	29-Mar-14	$	(5,659	)	$	(4,986	)	$	(1,527	)	$	(134	)	$	—		$	(12,306	)

Income_Taxes

Income Taxes	9 Months Ended
	Mar. 29, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes [Text Block]	'
	INCOME TAXES
	In the three and nine months ended March 29, 2014, the Company recorded an income tax provision (benefit) of $(10.6) million and $31.6 million, respectively, compared to an income tax provision of $22.8 million and $92.7 million in the three and nine months ended March 30, 2013, respectively. In addition, the Company recorded income tax that was netted against income from discontinued operations of $0.7 million for the three and nine months ended March 30, 2013. The Company’s effective tax rate for the three and nine months ended March 29, 2014 was (9.5)% and 10.5%, respectively, compared to 15.1% and 21.8%, respectively, for the three and nine months ended March 30, 2013.
	The Company's federal statutory tax rate is 35%. The Company's effective tax rates for the three and nine months ended March 29, 2014 were lower than the statutory tax rate primarily because earnings of foreign subsidiaries, generated primarily by our Irish operations, were taxed at lower rates and a $34.6 million one-time discrete benefit for fixed asset tax basis adjustments related to prior year depreciation expense.
	The Company’s effective tax rates for the three and nine months ended March 30, 2013 were lower than the statutory tax rate primarily because earnings of foreign subsidiaries, generated primarily by our Irish operations, were taxed at lower rates. The Company’s income tax provision for the three and nine months ended March 30, 2013 included a $7.1 million benefit for research tax credits for fiscal year 2012 and the first two quarters of fiscal year 2013 that were generated by the retroactive extension of the federal research tax credit to January 1, 2012 by legislation that was signed into law on January 2, 2013. The Company's income tax provision for the nine months ended March 30, 2013 included a $21.4 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit was available.
	The Company estimates it is reasonably possible that our liability for unrecognized tax benefits (income taxes payable), including accrued interest and penalties, could decrease within the next 12 months by $26 million due to expected settlements with various tax authorities.
	The Company’s federal corporate income tax returns are audited on a recurring basis by the IRS. In fiscal year 2012 the U.S. Internal Revenue Service commenced an audit of the Company's federal corporate income tax returns for fiscal years 2009 through 2011, which is still ongoing.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 29, 2014
Product Warranties Disclosures [Abstract]	'
Commitments and Contingencies [Text Block]	'
	COMMITMENTS AND CONTINGENCIES
	Legal Proceedings
	The Company is a party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual-property matters. While the outcome of these matters cannot be predicted with certainty, we do not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any.
	Indemnification
	The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees and damages and costs awarded against such parties in certain circumstances in which the Company’s products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company’s indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company’s potential liability for indemnification relating to intellectual property infringement claims.
	Pursuant to the Company’s charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.
	Product Warranty
	The Company generally warrants its products for one year from the date of shipment against defects in materials, workmanship and material non-conformance to the Company’s specifications. The general warranty policy provides for the repair or replacement of defective products or a credit to the customer’s account. In addition, the Company may consider its relationship with the customer when reviewing product claims. In limited circumstances and for strategic customers in certain unique industries and applications, our product warranty may extend for up to five years, and may also include financial responsibility, such as the payment of monetary compensation to reimburse a customer for its financial losses above and beyond repairing or replacing the product or crediting the customer’s account should the product not meet the Company’s specifications and losses and /or damages results from the defective product. The Company’s results of operations for the three months ended December 28, 2013 include a charge of $18.1 million primarily related to a product claim with a major customer. This charge includes product replacement and the cost to remove and install replacement product. Additionally, the Company assumed $13.9 million of warranty claims from Volterra in connection with the Company’s acquisition of Volterra on October 1, 2013.
	Accruals are based on specifically identified claims and on the estimated, undiscounted cost of incurred-but-not-reported claims. If there is a material increase in the rate of customer claims compared with our historical experience or if the Company's estimates of probable losses relating to specifically identified warranty exposures require revision, the Company may record a charge against future cost of sales. Product warranty liability is included within the balance sheet captions “Accrued Expenses” and “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets.
	The changes in the Company's aggregate product warranty liabilities for the nine months ended March 29, 2014 were as follows:
		(in thousands)
	Product warranty liability at June 29, 2013	$	3,075
	Accruals assumed from acquisition	13,911
	Accruals for warranties	19,640
	Payments	(12,776		)
	Changes in estimate	187
	Product warranty liability at March 29, 2014	$	24,037

Common_Stock_Repurchases

Common Stock Repurchases	9 Months Ended
	Mar. 29, 2014
Common Stock Repurchases [Abstract]	'
Common Stock Repurchases [Text Block]	'
	COMMON STOCK REPURCHASES
	In July 2013, the Board of Directors authorized the Company to repurchase up to $1 billion of the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company’s Board of Directors for the repurchase of common stock were superseded by this authorization.
	During the nine months ended March 29, 2014, the Company repurchased approximately 9.2 million shares of its common stock based on settlement date for $264.6 million. As of March 29, 2014, the Company had remaining authorization of $802.6 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

Acquisitions_Notes

Acquisitions (Notes)	9 Months Ended
	Mar. 29, 2014
Business Acquisition [Line Items]	'
Business Combination Disclosure [Text Block]	'
	ACQUISITIONS
	Acquisitions completed in fiscal year 2014
	The Company completed two acquisitions during fiscal year 2014.
	VOLTERRA
	On October 1, 2013, the Company completed its acquisition of Volterra, formerly a publicly traded company that develops power management solutions. The primary reason for this acquisition was to expand the Company's available market across a wide range of end markets, including enterprise server, cloud computing, communications and energy. The results of operations of Volterra are included in the Company’s Condensed Consolidated Statements of Income, beginning in the second quarter of fiscal year 2014. Acquisition-related costs for the nine months ended March 29, 2014 were $7.0 million. The Company is in the process of integrating the Volterra acquisition with the existing Communications and Automotive Solutions Group.
	The total purchase price for Volterra was approximately $615 million and was comprised of:
			(in thousands)
	Cash consideration for 100% of outstanding common stock of Volterra at $23 per share		$	593,250
	Cash consideration for vested options settlement		21,756
	Total preliminary purchase price		$	615,006
	Volterra Substitute Awards
	In connection with the acquisition, the Company issued substitute awards to certain Volterra employees. Refer to Note 6: “Stock-Based Compensation” of these Notes to Condensed Consolidated Financial Statements for further discussion on stock compensation in relation to Volterra.
	The preliminary purchase price allocation as of the date of the acquisition is set forth in the table below and reflects various fair value estimates and analysis. These estimates were determined through established and generally accepted valuation techniques, including preliminary work performed by third-party valuation specialists, and are subject to change during the purchase price allocation period (generally one year from the acquisition date) as valuations are finalized.
		Volterra
		(in thousands)
	Cash and cash equivalents and short-term investments	$	163,500
	Accounts receivable	23,453
	Inventories	33,339
	Other tangible assets	17,151
	Accrued expenses	(35,343		)
	Income taxes payable	(23,241		)
	Other liabilities assumed	(20,149		)
	Net tangible assets	158,710
	Amortizable intangible assets	226,900
	In-process research and development ("IPR&D")	56,200
	Goodwill	174,894
	Substitution of stock-based compensation awards	(1,698		)
	Total purchase price	$	615,006
	The fair value of property, plant, and equipment and intangible assets is preliminary pending the completion of the valuation of those assets. In addition, the Company has evaluated and continues to evaluate certain pre-acquisition contingencies, including corporate income tax related payables, uncertain tax positions and certain legal contingencies, relating to Volterra that existed as of the acquisition date. Additional information, which existed as of the acquisition date but was at that time unknown to the Company, may become known to the Company during the remainder of the purchase price allocation period.
	IPR&D assets relate to future technology, is capitalized until the technology is ready for its intended use and then amortized over the technology useful life. IPR&D costs incurred by the Company subsequent to the acquisition are expensed.
	Goodwill was primarily attributable to the opportunities from the addition of Volterra's product portfolio which complements the Company’s suite of products, including providing integrated process solutions to customers. The goodwill is not deductible for tax purposes.
	The amortizable intangible assets are being amortized on a straight-line basis over their estimated useful lives as follows:
		Volterra acquisition
		Fair value			Weighted average useful life (in years)
		( in thousands)
	Intellectual property	$	192,500		4.9
	Customer relationships	24,600			9.6
	Trade name	6,400			4
	Backlog	900			0.4
	Patents	2,500			4.8
	Total amortizable intangible assets	$	226,900
	Pro forma results of operations for this acquisition have not been presented because it is not material to the Company's Condensed Consolidated Statements of Income.
	Refer to Note 16: "Restructuring Activities" of these Notes to Condensed Consolidated Financial Statements for a discussion on Volterra Restructuring Plan.
	OTHER ACQUISITION
	The Company acquired another company during the nine months ended March 29, 2014, which develops low power high performance analog circuits. The total cash consideration in exchange for 100% of the outstanding shares, for this acquisition was approximately $6.1 million for which the purchase price was largely attributable to the acquired developed intellectual property. Acquisition related costs were not material for this transaction.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	9 Months Ended
	Mar. 29, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets [Text Block]	'
	GOODWILL AND INTANGIBLE ASSETS
	Goodwill
	The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company performed the annual goodwill impairment analysis during the first quarter of fiscal year 2014 and concluded that goodwill was not impaired, as the fair value of each reporting unit exceeded its carrying value.
	Activity and goodwill balances for the nine months ended March 29, 2014 were as follows:
		Goodwill
		(in thousands)
	Balance at June 29, 2013	$	422,004
	Acquisitions	175,493
	Adjustments	179
	Balance at March 29, 2014	$	597,676
	Intangible Assets
	The useful lives of amortizable intangible assets are as follows:
	Asset		Life
	Intellectual property		3 months-10 years
	Customer relationships		5-10 years
	Trade name		3-4 years
	Backlog		4 months
	Patents		5 years
	Intangible assets consisted of the following:
		March 29, 2014							June 29, 2013
		Original			Accumulated		Net		Original		Accumulated		Net
		Cost			Amortization				Cost		Amortization
		(in thousands)
	Intellectual property	$	435,962		$	182,773	$	253,189	$	230,562	$	136,870	$	93,692
	Customer relationships	120,230			65,262		54,968		95,230		54,308		40,922
	Tradename	8,500			2,836		5,664		2,100		1,950		150
	Backlog	1,000			1,000		—		—		—		—
	Patent	2,500			256		2,244		—		—		—
	Total amortizable purchased intangible assets	568,192			252,127		316,065		327,892		193,128		134,764
	IPR&D	68,102			—		68,102		22,382		—		22,382
	Total purchased intangible assets	$	636,294		$	252,127	$	384,167	$	350,274	$	193,128	$	157,146
	The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:
		Three Months Ended					Nine Months Ended
		March 29,			March 30,		March 29,		March 30,
		2014			2013		2014		2013
		(in thousands)
	Cost of goods sold	$	18,542		$	7,777	$	45,732	$	26,217
	Intangible asset amortization	4,863			3,903		13,267		11,855
	Total intangible asset amortization expenses	$	23,405		$	11,680	$	58,999	$	38,072
	The following table represents the estimated future amortization expense of intangible assets as of March 29, 2014:
	Fiscal Year		Amount
			(in thousands)
	Remaining three months of 2014		$	23,172
	2015		90,443
	2016		74,454
	2017		61,782
	2018		41,927
	2019		13,278
	Thereafter		11,009
	Total intangible assets		$	316,065

Impairment_of_LongLived_Assets

Impairment of Long-Lived Assets (Notes)	9 Months Ended
	Mar. 29, 2014
impairment of long life assets [Abstract]	'
Impairment of Long Lived Assets Disclosure [Text Block]	'
	IMPAIRMENT OF LONG-LIVED ASSETS
	Fiscal year 2014:
	During the second quarter of fiscal year 2014, the Company recorded $5.2 million in Impairment of long-lived assets in the Company's Condensed Consolidated Statements of Income.
	The impairment includes certain U.S. test operation assets identified as excess and no longer needed. These assets included primarily test manufacturing equipment which was recorded in Property, plant, and equipment, net in the Condensed Consolidated Balance Sheet as of March 29, 2014. The company also impaired fab tools and a building classified as held for sale. The fab tools were fully impaired while the building was impaired down to fair value less cost to sell. The fair value of the building was determined mainly after consideration of evidence such as broker estimates, building condition, and offers received.
	Fiscal year 2013:
	During the second quarter of fiscal year 2013, the Company identified certain assets as excess primarily attributable to the transition to utilizing newer, more efficient manufacturing equipment. These assets included used fabrication tools and test manufacturing equipment. In connection with these circumstances, the Company recorded a charge for the write down of equipment to its estimated fair value. The total charge of $22.2 million was included in Impairment of long-lived assets in the Company's Condensed Consolidated Statements of Income. The Company reached its conclusion regarding the asset impairment after conducting an evaluation of assets fair values. The fair value of the equipment was determined mainly after consideration of quoted market prices of similar equipment adjusted for equipment specifications and condition in addition to the current market demand and size.
	During the first quarter of fiscal year 2013, the Company identified certain idle facilities as held for sale. In connection with these circumstances, the Company recorded a charge for the write-down of land and buildings to their estimated fair value, less cost to sell. The total charge of $2.7 million was included in impairment of long-lived assets in the Company's Condensed Consolidated Statements of Income. The Company reached its conclusion regarding the asset impairment after conducting an evaluation of assets fair values. The fair value of the land and buildings was determined mainly after consideration of evidence such as appraisals and offers received.

Restructuring_Activities_Notes

Restructuring Activities (Notes)	9 Months Ended
	Mar. 29, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Activities Disclosure [Text Block]	'
	RESTRUCTURING ACTIVITIES
	Volterra Restructuring Plan
	In connection with the acquisitions of Volterra, the Company's management approved and initiated plans to restructure the operations of Volterra, including acceleration of certain stock-based compensation awards, costs to vacate duplicative facilities, severance for transitional and exiting employees, contract cancellation costs and other items. The total combined cost of the plan was $10.6 million in Severance and restructuring expenses in the Company's Condensed Consolidated Statements of Income. As of March 29, 2014, the Company recorded all of the costs of the plan based upon the anticipated timing of planned terminations and facility closure costs. Expected severance and retention costs for transitional employees are being accrued over the transitional period. Amounts accrued and future estimated costs to be incurred as of March 29, 2014 are immaterial.
	Business Unit Reorganization
	During the nine months ended March 29, 2014, the Company recorded $8.5 million in Severance and restructuring expenses in the Company's Condensed Consolidated Statements of Income associated with the reorganization of certain business units. Multiple job classifications and locations were impacted as this was a company-wide action. The reorganization was driven by the desire to focus on specific investment areas and simplify business processes.

Balance_Sheet_Components_Table

Balance Sheet Components (Tables)	9 Months Ended
	Mar. 29, 2014
Balance Sheet Related Disclosures [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
	Accounts receivable, net consists of:
		March 29,			June 29,
		2014			2013
	Accounts Receivable:	(in thousands)
	Accounts receivable	$	320,363		$	299,083
	Returns and allowances	(16,235		)	(13,645		)
		$	304,128		$	285,438
Schedule of Inventory, Current [Table Text Block]	'
	Inventories consist of:
		March 29,			June 29,
		2014			2013
	Inventories:	(in thousands)
	Raw materials	$	13,906		$	14,055
	Work-in-process	186,249			184,511
	Finished goods	90,363			77,074
		$	290,518		$	275,640
Property, Plant and Equipment [Table Text Block]	'
	Property, plant and equipment, net consists of:
		March 29,			June 29,
		2014			2013
	Property, plant and equipment:	(in thousands)
	Land	$	62,093		$	62,093
	Buildings and building improvements	376,112			364,037
	Machinery and equipment	2,146,411			2,099,301
		2,584,616			2,525,431
	Less: accumulated depreciation and amortization	(1,229,348		)	(1,152,307		)
		$	1,355,268		$	1,373,124

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Mar. 29, 2014
Fair Value Disclosures [Abstract]	'
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
	Assets and liabilities measured at fair value on a recurring basis were as follows:
		As of March 29, 2014												As of June 29, 2013
		Fair Value										Total		Fair Value						Total
		Measurements Using										Balance		Measurements Using						Balance
		Level 1				Level 2				Level 3				Level 1		Level 2		Level 3
		(in thousands)
	Assets
	Money market funds (1)	$	744,979			$	—			$	—	$	744,979	$	402,513	$	—	$	—	$	402,513
	Certificates of deposit (1)	—				—				—		—		—		77		—		77
	Government agency securities (2)	—				—				—		—		—		25,060		—		25,060
	Foreign currency forward contracts (3)	—				157				—		157		—		187		—		187
	Total Assets	$	744,979			$	157			$	—	$	745,136	$	402,513	$	25,324	$	—	$	427,837
	Liabilities
	Foreign currency forward contracts (4)	$	—			$	399			$	—	$	399	$	—	$	1,419	$	—	$	1,419
	Contingent Consideration (4)	—				—				4,358		4,358		—		—		8,577		8,577
	Total Liabilities	$	—			$	399			$	4,358	$	4,757	$	—	$	1,419	$	8,577	$	9,996
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
	The tables below present reconciliations for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended March 29, 2014 and March 30, 2013:
	Fair Value Measured and Recorded Using Significant Unobservable Inputs (Level 3)
			March 29,				March 30,
			2014				2013
	Contingent Consideration		(in thousands)
	Beginning balance		$	8,577			$	17,737
	Total gains or losses (realized and unrealized):
	Included in earnings		1,632				3,226
	Payments		(5,851		)		(7,476		)
	Ending balance		$	4,358			$	13,487
	Changes in unrealized losses (gains) included in earnings related to liabilities still held as of period end		$	1,632			$	3,226

Financial_Instruments_Tables

Financial Instruments (Tables)	9 Months Ended
	Mar. 29, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Available-for-sale investments [Table Text Block]	'
	Fair values were as follows:
		March 29, 2014										June 29, 2013
		Amortized Cost			Gross Unrealized Gain			Gross Unrealized Loss		Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value
		(in thousands)
	Available-for-sale investments
	Government agency securities	$	—		$	—		$	—	$	—	$	25,024	$	36	$	—	$	25,060
	Total available-for-sale investments	$	—		$	—		$	—	$	—	$	25,024	$	36	$	—	$	25,060
Schedule of long-term debt [Table Text Block]	'
	The following table summarizes the Company’s long-term debt:
		March 29,			June 29,
		2014			2013
		(in thousands)
	3.375% fixed rate notes due March 2023	$	500,000		$	500,000
	2.5% fixed rate notes due November 2018	500,000			—
	Notes denominated in Euro
	Amortizing floating rate notes (EURIBOR plus 1.5%) due up to June 2014	2,526			4,804
	Term fixed rate notes (2.0%-2.5%) due up to September 2015	871			784
	Total	1,003,397			505,588
	Less: Current portion	(2,526		)	(2,015		)
	Total long-term debt	$	1,000,871		$	503,573

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Mar. 29, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	'
	The following table shows total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 29, 2014 and March 30, 2013:
		Three Months Ended
		March 29, 2014												March 30, 2013
		Stock Options			Restricted Stock Units				Employee Stock Purchase Plan			Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
		(in thousands)
	Cost of goods sold	$	451		$	2,108			$	594		$	3,153	$	337	$	2,120	$	598	$	3,055
	Research and development	2,124			7,917				1,623			11,664		1,440		7,116		1,480		10,036
	Selling, general and administrative	1,391			5,186				663			7,240		1,157		4,764		601		6,522
	Pre-tax stock-based compensation expense	$	3,966		$	15,211			$	2,880		$	22,057	$	2,934	$	14,000	$	2,679	$	19,613
	Less: income tax effect											3,400								2,847
	Net stock-based compensation expense											$	18,657							$	16,766
		Nine Months Ended
		March 29, 2014												March 30, 2013
		Stock Options			Restricted Stock Units				Employee Stock Purchase Plan			Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
		(in thousands)
	Cost of goods sold	$	1,238		$	6,421			$	1,602		$	9,261	$	1,212	$	6,863	$	1,651	$	9,726
	Research and development	6,576			23,085				4,098			33,759		5,557		24,727		4,215		34,499
	Selling, general and administrative	4,131			14,709				1,806			20,646		3,998		15,035		1,697		20,730
	Pre-tax stock-based compensation expense	$	11,945		$	44,215			$	7,506		$	63,666	$	10,767	$	46,625	$	7,563	$	64,955
	Less: income tax effect											9,878								11,617
	Net stock-based compensation expense											$	53,788							$	53,338
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
	The fair value of options granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions:
		Stock Options (1)
		Three Months Ended					Nine Months Ended
		March 29,		March 30,			March 29,			March 30,
		2014		2013			2014			2013
	Expected holding period (in years)	4.9		4.9			5.3			5.3
	Risk-free interest rate	1.6	%	0.8	%		1.4	%		0.7	%
	Expected stock price volatility	30.2	%	37.5	%		34.8	%		37.8	%
	Dividend yield	3.6	%	3.4	%		3.2	%		3.3	%
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	'
	The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 29, 2014 and their activity for the nine months ended March 29, 2014:
		Number of		Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (in Years)		Aggregate Intrinsic Value (1)
		Shares
	Balance at June 29, 2013	20,081,339		$	26
	Options Granted	2,882,740		27.17
	Volterra substitute options granted	673,185		22.26
	Options Exercised	(2,267,719	)	18.07
	Options Cancelled	(3,042,128	)	32.25
	Balance at March 29, 2014	18,327,417		$	26.04			3.6		$	148,116,516
	Exercisable, March 29, 2014	8,592,118		$	27.62			1.9		$	69,970,388
	Vested and expected to vest, March 29, 2014	17,245,995		$	26.01			3.5		$	141,248,804
	-1	Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 28, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 29, 2014.
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]	'
	The following table summarizes outstanding and expected to vest RSUs as of March 29, 2014 and their activity during the nine months ended March 29, 2014:
		Number of		Weighted Average		Aggregate Intrinsic
		Shares		Remaining		Value (1)
				Contractual Term
				(in Years)
	Balance at June 29, 2013	7,965,532
	Restricted stock units granted	3,387,079
	Volterra substitute restricted stock units granted	418,955
	Restricted stock units released	(2,141,883	)
	Restricted stock units cancelled	(903,922	)
	Balance at March 29, 2014	8,725,761		2.7		$	284,624,813
	Outstanding and expected to vest, March 29, 2014	7,626,649		2.7		$	249,086,361
	-1	Aggregate intrinsic value for RSUs represents the closing price per share of the Company’s common stock on March 28, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 29, 2014.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]	'
	The fair value of ESPP granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following weighted-average assumptions:
		ESPP
		Three Months Ended					Nine Months Ended
		March 29,		March 30,			March 29,			March 30,
		2014		2013			2014			2013
	Expected holding period (in years)	0.5		0.5			0.5			0.5
	Risk-free interest rate	0.1	%	0.1	%		0.1	%		0.1	%
	Expected stock price volatility	21.7	%	26.1	%		21.7	%		26.1	%
	Dividend yield	3.7	%	3.6	%		3.7	%		3.6	%

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	9 Months Ended
	Mar. 29, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	The following table sets forth the computation of basic and diluted earnings per share:
		Three Months Ended				Nine Months Ended
		March 29,		March 30,		March 29,		March 30,
		2014		2013		2014		2013
		(in thousands, except per share data)
	Numerator for basic earnings per share and diluted earnings per share
	Net income	$	122,544	$	131,388	$	270,017	$	335,898
	Denominator for basic earnings per share	282,627		292,888		283,315		292,048
	Effect of dilutive securities:
	Stock options, ESPP and RSUs	5,948		7,194		5,807		6,773
	Denominator for diluted earnings per share	288,575		300,082		289,122		298,821
	Earnings per share: basic
	From continuing operations	$	0.43	$	0.44	$	0.95	$	1.14
	From discontinued operations	—		0.01		—		0.01
	Basic	$	0.43	$	0.45	$	0.95	$	1.15
	Earnings per share: diluted
	From continuing operations	$	0.42	$	0.43	$	0.93	$	1.11
	From discontinued operations	—		0.01		—		0.01
	Diluted	$	0.42	$	0.44	$	0.93	$	1.12

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Mar. 29, 2014
Segment Reporting [Abstract]	'
Schedule of Revenue from External Customers by Geographical Areas [Table Text Block]	'
	Net revenues from unaffiliated customers by geographic region were as follows:
			Three Months Ended					Nine Months Ended
			March 29,			March 30,		March 29,		March 30,
			2014			2013		2014		2013
			(in thousands)
	United States		$	68,944		$	63,784	$	241,082	$	185,765
	China		240,677			225,808		745,886		767,192
	Korea		33,217			73,362		101,979		194,357
	Rest of Asia		160,703			151,231		444,270		425,904
	Europe		84,005			75,734		230,032		213,582
	Rest of World		18,135			14,965		47,947		46,465
			$	605,681		$	604,884	$	1,811,196	$	1,833,265
Schedule of Long Lived Assets by Geographical Areas [Table Text Block]	'
	Net long-lived assets by geographic region were as follows:
		March 29,			June 29,
		2014			2013
		(in thousands)
	United States	$	1,057,881		$	1,058,579
	Philippines	175,636			183,671
	Rest of World	121,751			130,874
		$	1,355,268		$	1,373,124

Comprehensive_Income_Tables

Comprehensive Income (Tables)	9 Months Ended
	Mar. 29, 2014
Statement of Comprehensive Income [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	The changes in accumulated other comprehensive loss by component and related tax effects in the nine months ended March 29, 2014 were as follows:
	(in thousands)	Unrealized gain (loss) on intercompany receivables			Unrealized gain (loss) on post-retirement benefits			Cumulative translation adjustment			Unrealized gain (loss) on cash flow hedges			Unrealized gain (loss) on available-for-sale securities			Total
	29-Jun-13	$	(7,401	)	$	(5,838	)	$	(1,527	)	$	(1,004	)	$	23		$	(15,747	)
	Other comprehensive income (loss) before reclassifications	—			—			—			(465		)	(36		)	(501		)
	Amounts reclassified out of accumulated other comprehensive income (loss)	—			1,076			—			1,525			—			2,601
	Tax effects	1,742			(224		)	—			(190		)	13			1,341
	Other comprehensive income (loss)	1,742			852			—			870			(23		)	3,441
	29-Mar-14	$	(5,659	)	$	(4,986	)	$	(1,527	)	$	(134	)	$	—		$	(12,306	)

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	9 Months Ended
	Mar. 29, 2014
Product Warranties Disclosures [Abstract]	'
Schedule of Product Warranty Liability [Table Text Block]	'
	The changes in the Company's aggregate product warranty liabilities for the nine months ended March 29, 2014 were as follows:
		(in thousands)
	Product warranty liability at June 29, 2013	$	3,075
	Accruals assumed from acquisition	13,911
	Accruals for warranties	19,640
	Payments	(12,776		)
	Changes in estimate	187
	Product warranty liability at March 29, 2014	$	24,037

Acquisitions_Tables

Acquisitions (Tables)	9 Months Ended
	Mar. 29, 2014
Business Combinations [Abstract]	'
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	'
	The total purchase price for Volterra was approximately $615 million and was comprised of:
			(in thousands)
	Cash consideration for 100% of outstanding common stock of Volterra at $23 per share		$	593,250
	Cash consideration for vested options settlement		21,756
	Total preliminary purchase price		$	615,006
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	The preliminary purchase price allocation as of the date of the acquisition is set forth in the table below and reflects various fair value estimates and analysis. These estimates were determined through established and generally accepted valuation techniques, including preliminary work performed by third-party valuation specialists, and are subject to change during the purchase price allocation period (generally one year from the acquisition date) as valuations are finalized.
		Volterra
		(in thousands)
	Cash and cash equivalents and short-term investments	$	163,500
	Accounts receivable	23,453
	Inventories	33,339
	Other tangible assets	17,151
	Accrued expenses	(35,343		)
	Income taxes payable	(23,241		)
	Other liabilities assumed	(20,149		)
	Net tangible assets	158,710
	Amortizable intangible assets	226,900
	In-process research and development ("IPR&D")	56,200
	Goodwill	174,894
	Substitution of stock-based compensation awards	(1,698		)
	Total purchase price	$	615,006
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]	'
	The amortizable intangible assets are being amortized on a straight-line basis over their estimated useful lives as follows:
		Volterra acquisition
		Fair value			Weighted average useful life (in years)
		( in thousands)
	Intellectual property	$	192,500		4.9
	Customer relationships	24,600			9.6
	Trade name	6,400			4
	Backlog	900			0.4
	Patents	2,500			4.8
	Total amortizable intangible assets	$	226,900

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Mar. 29, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill [Table Text Block]	'
	Activity and goodwill balances for the nine months ended March 29, 2014 were as follows:
		Goodwill
		(in thousands)
	Balance at June 29, 2013	$	422,004
	Acquisitions	175,493
	Adjustments	179
	Balance at March 29, 2014	$	597,676
Useful lives of definite lived intangible assets [Table Text Block]	'
	The useful lives of amortizable intangible assets are as follows:
	Asset		Life
	Intellectual property		3 months-10 years
	Customer relationships		5-10 years
	Trade name		3-4 years
	Backlog		4 months
	Patents		5 years
Schedule of intangible assets [Table Text Block]	'
	Intangible assets consisted of the following:
		March 29, 2014							June 29, 2013
		Original			Accumulated		Net		Original		Accumulated		Net
		Cost			Amortization				Cost		Amortization
		(in thousands)
	Intellectual property	$	435,962		$	182,773	$	253,189	$	230,562	$	136,870	$	93,692
	Customer relationships	120,230			65,262		54,968		95,230		54,308		40,922
	Tradename	8,500			2,836		5,664		2,100		1,950		150
	Backlog	1,000			1,000		—		—		—		—
	Patent	2,500			256		2,244		—		—		—
	Total amortizable purchased intangible assets	568,192			252,127		316,065		327,892		193,128		134,764
	IPR&D	68,102			—		68,102		22,382		—		22,382
	Total purchased intangible assets	$	636,294		$	252,127	$	384,167	$	350,274	$	193,128	$	157,146
Schedule of amortization expense allocation of intangible assets [Table Text Block]	'
	The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:
		Three Months Ended					Nine Months Ended
		March 29,			March 30,		March 29,		March 30,
		2014			2013		2014		2013
		(in thousands)
	Cost of goods sold	$	18,542		$	7,777	$	45,732	$	26,217
	Intangible asset amortization	4,863			3,903		13,267		11,855
	Total intangible asset amortization expenses	$	23,405		$	11,680	$	58,999	$	38,072
Estimated future amortization expense of intangible assets [Table Text Block]	'
	The following table represents the estimated future amortization expense of intangible assets as of March 29, 2014:
	Fiscal Year		Amount
			(in thousands)
	Remaining three months of 2014		$	23,172
	2015		90,443
	2016		74,454
	2017		61,782
	2018		41,927
	2019		13,278
	Thereafter		11,009
	Total intangible assets		$	316,065

Basis_of_Presentation_Details

Basis of Presentation (Details)	9 Months Ended
	Mar. 29, 2014
Basis of Presentation [Abstract]	'
Frequency of 53 Week Fiscal Year	'fifth or sixth year
Fiscal Year Duration Range	'52-to-53-week
Number of Weeks in Current Fiscal Year	'P52W

Balance_Sheet_Components_Detai

Balance Sheet Components (Details) (USD $)	Mar. 29, 2014	Jun. 29, 2013
In Thousands, unless otherwise specified
Accounts Receivables:	'	'
Accounts receivable	$320,363	$299,083
Returns and allowances	-16,235	-13,645
Accounts receivable, net	304,128	285,438
Inventories:	'	'
Raw materials	13,906	14,055
Work-in-process	186,249	184,511
Finished goods	90,363	77,074
Inventory, net	290,518	275,640
Property, plant and equipment:	'	'
Land	62,093	62,093
Buildings and building improvements	376,112	364,037
Machinery and equipment	2,146,411	2,099,301
Property, plant and equipment, gross	2,584,616	2,525,431
Less: accumulated depreciation and amortization	-1,229,348	-1,152,307
Property, plant and equipment, net	$1,355,268	$1,373,124

Fair_Value_Measurements_Detail

Fair Value Measurements (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014		Mar. 30, 2013	Jun. 29, 2013		Jun. 30, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	$1,231,248		$1,547,980	$1,174,986		$881,060
Government agency securities	0		'	25,060		'
Fair Value, Measurements, Nonrecurring [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis	0		'	'		'
Fair Value, Measurements, Recurring [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	'		'	8,577		17,737
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales	1,632		3,226	'		'
Business acquisition,cash paid for contingent consideration	-5,851		-7,476	'		'
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	4,358		13,487	8,577		17,737
Fair Value, Assets Measured on Recurring Basis, Change in Unrealized Gain (Loss) Included in Other Income	1,632		3,226	'		'
Fair Value, Assets and Liabilities Class [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Total Assets	745,136		'	427,837		'
Total Liabilities	4,757		'	9,996		'
Fair Value, Assets and Liabilities Class [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 1 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Total Assets	744,979		'	402,513		'
Total Liabilities	0		'	0		'
Fair Value, Assets and Liabilities Class [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 2 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Total Assets	157		'	25,324		'
Total Liabilities	399		'	1,419		'
Fair Value, Assets and Liabilities Class [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 3 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Total Assets	0		'	0		'
Total Liabilities	4,358		'	8,577		'
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	744,979	[1]	'	402,513	[1]	'
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 1 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	744,979	[1]	'	402,513	[1]	'
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 2 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	0	[1]	'	0	[1]	'
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 3 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	0	[1]	'	0	[1]	'
Certificates of Deposit [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	0	[1]	'	77	[1]	'
Certificates of Deposit [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 1 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	0	[1]	'	0	[1]	'
Certificates of Deposit [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 2 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	0	[1]	'	77	[1]	'
Certificates of Deposit [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 3 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Cash and cash equivalents	0	[1]	'	0	[1]	'
Government agency securities [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Government agency securities	0	[2]	'	25,060	[2]	'
Government agency securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 1 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Government agency securities	0	[2]	'	0	[2]	'
Government agency securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 2 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Government agency securities	0	[2]	'	25,060	[2]	'
Government agency securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 3 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Government agency securities	0	[2]	'	0	[2]	'
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Foreign currency forward contracts	157	[3]	'	187	[3]	'
Foreign currency forward contracts	399	[4]	'	1,419	[4]	'
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 1 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Foreign currency forward contracts	0	[3]	'	0	[3]	'
Foreign currency forward contracts	0	[4]	'	0	[4]	'
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 2 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Foreign currency forward contracts	157	[3]	'	187	[3]	'
Foreign currency forward contracts	399	[4]	'	1,419	[4]	'
Foreign Exchange Forward [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 3 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Foreign currency forward contracts	0	[3]	'	0	[3]	'
Foreign currency forward contracts	0	[4]	'	0	[4]	'
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Contingent Consideration	4,358	[4]	'	8,577	[4]	'
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 1 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Contingent Consideration	0	[4]	'	0	[4]	'
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 2 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Contingent Consideration	0	[4]	'	0	[4]	'
Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value Measurements Using Level 3 [Member]	'		'	'		'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'		'	'		'
Contingent Consideration	$4,358	[4]	'	$8,577	[4]	'
[1]	Included in Cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets.
[2]	Included in Short-term investments in the accompanying Condensed Consolidated Balance Sheets.
[3]	Included in Other current assets in the accompanying Condensed Consolidated Balance Sheets.
[4]	Included in Accrued expenses in the accompanying Condensed Consolidated Balance Sheets.

Financial_Instruments_Shortter

Financial Instruments, Short-term Investments (Details) (USD $)	9 Months Ended	12 Months Ended
	Mar. 29, 2014	Jun. 29, 2013
Available-for-sale Securities [Abstract]	'	'
Amortized Cost	$0	$25,024,000
Gross Unrealized Gains	0	36,000
Gross Unrealized Loss	0	0
Estimated Fair Value	0	25,060,000
Short-Term Investment [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Other than Temporary Impairment Losses, Investments, Available-for-sale Securities	0	0
Government agency securities [Member]	'	'
Available-for-sale Securities [Abstract]	'	'
Amortized Cost	0	25,024,000
Gross Unrealized Gains	0	36,000
Gross Unrealized Loss	0	0
Estimated Fair Value	$0	$25,060,000

Financial_Instruments_Balance_

Financial Instruments, Balance Sheet Location (Details) (USD $)	Mar. 29, 2014	Jun. 29, 2013
In Millions, unless otherwise specified
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Forward contracts held to purchase U.S. dollars [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Notional amount of derivatives	$52.90	$53.80
Derivatives designated as hedging instruments [Member] | Cash Flow Hedging [Member] | Forward contracts held to sell U.S. dollars [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Notional amount of derivatives	1.4	3.2
Derivatives not designated as hedging instruments [Member] | Forward contracts held to purchase U.S. dollars [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Notional amount of derivatives	15.9	15
Derivatives not designated as hedging instruments [Member] | Forward contracts held to sell U.S. dollars [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Notional amount of derivatives	$31.10	$36.50

Financial_Instruments_Longterm

Financial Instruments, Long-term Debt (Details) (USD $)

3 Months Ended

9 Months Ended

9 Months Ended

9 Months Ended

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Mar. 30, 2013

Jun. 29, 2013

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Dec. 28, 2013

Jun. 29, 2013

Mar. 29, 2014

Jun. 29, 2013

Mar. 29, 2014

Jun. 29, 2013

Mar. 29, 2014

Fixed Rate Note Due March 2023 at 3 Point 375 Percent [Member]

Fixed Rate Note Due March 2023 at 3 Point 375 Percent [Member]

Fixed Rate Note Due November 2018 at 2 Point 50 Percent [Member]

Fixed Rate Note Due November 2018 at 2 Point 50 Percent [Member]

Fixed Rate Note Due November 2018 at 2 Point 50 Percent [Member]

Term fixed rate notes (2.0%-2.5%) due up to September 2015 [Member]

Term fixed rate notes (2.0%-2.5%) due up to September 2015 [Member]

Amortizing floating rate notes (EURIBOR plus 1.5%) due up to June 2014 [Member]

Amortizing floating rate notes (EURIBOR plus 1.5%) due up to June 2014 [Member]

Fxed Rate Note Due March 2023 at 3 Point 375 Percent [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term debt

$1,003,397,000

'

$1,003,397,000

'

$505,588,000

'

$500,000,000

'

$500,000,000

$0

$871,000

$784,000

$2,526,000

$4,804,000

'

Long-term debt, current portion

-2,526,000

'

-2,526,000

'

-2,015,000

'

'

'

'

'

'

'

'

'

'

Long-term debt, excluding current portion

1,000,871,000

'

1,000,871,000

'

503,573,000

'

'

'

'

'

'

'

'

'

'

Stated interest rate of the notes

'

'

'

'

'

3.38%

3.38%

'

2.50%

'

'

'

'

'

'

Effective interest rate of the Notes

'

'

'

'

'

'

3.50%

'

2.60%

'

'

'

'

'

'

Net Proceeds From Issuance of Long Term Debt 4

'

'

'

'

'

'

'

494,500,000

'

'

'

'

'

'

490,000,000

Interest expense relating to the Notes

7,400,000

3,800,000

17,300,000

9,600,000

'

'

'

'

'

'

'

'

'

'

'

Estimated fair value of long-term debt

$983,000,000

'

$983,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Minimum stated interest rate of notes

'

'

'

'

'

'

'

'

'

'

2.00%

'

'

'

'

Maximum stated interest rate of notes

'

'

'

'

'

'

'

'

'

'

2.50%

'

'

'

'

Floating rate notes, rate basis

'

'

'

'

'

'

'

'

'

'

'

'

'EURIBOR

'

'

Debt Instrument, Basis Spread on Variable Rate

'

'

'

'

'

'

'

'

'

'

'

'

1.50%

'

'

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	$22,057	$19,613	$63,666	$64,955
Less: Income tax effect	3,400	2,847	9,878	11,617
Net stock-based compensation expense	18,657	16,766	53,788	53,338
Cost of Sales [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	3,153	3,055	9,261	9,726
Research and Development Expense [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	11,664	10,036	33,759	34,499
General and Administrative Expense [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	7,240	6,522	20,646	20,730
Stock options [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	3,966	2,934	11,945	10,767
Stock options [Member] | Cost of Sales [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	451	337	1,238	1,212
Stock options [Member] | Research and Development Expense [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	2,124	1,440	6,576	5,557
Stock options [Member] | General and Administrative Expense [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	1,391	1,157	4,131	3,998
Restricted stock units [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	15,211	14,000	44,215	46,625
Restricted stock units [Member] | Cost of Sales [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	2,108	2,120	6,421	6,863
Restricted stock units [Member] | Research and Development Expense [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	7,917	7,116	23,085	24,727
Restricted stock units [Member] | General and Administrative Expense [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	5,186	4,764	14,709	15,035
ESP Plan [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	2,880	2,679	7,506	7,563
ESP Plan [Member] | Cost of Sales [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	594	598	1,602	1,651
ESP Plan [Member] | Research and Development Expense [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	1,623	1,480	4,098	4,215
ESP Plan [Member] | General and Administrative Expense [Member]	'	'	'	'
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]	'	'	'	'
Allocated Share-based Compensation Expense	$663	$601	$1,806	$1,697

StockBased_Compensation_Fair_V

Stock-Based Compensation, Fair Value of Options (Details) (USD $)	3 Months Ended				9 Months Ended
	Mar. 29, 2014		Mar. 30, 2013		Mar. 29, 2014		Mar. 30, 2013
Stock Option [Member]	'		'		'		'
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]	'		'		'		'
Options granted, weighted average fair value of stock options (per share)	$5.55		$7.39		$7.39		$6.69
Stock options [Member]	'		'		'		'
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]	'		'		'		'
Expected holding period (in years)	'4 years 10 months 24 days	[1]	'4 years 10 months 24 days	[1]	'5 years 3 months 18 days	[1]	'5 years 3 months 18 days	[1]
Risk-free interest rate	1.60%	[1]	0.80%		1.40%	[1]	0.70%	[1]
Expected stock price volatility	30.20%	[1]	37.50%		34.80%	[1]	37.80%	[1]
Dividend yield	3.60%	[1]	3.40%		3.20%	[1]	3.30%	[1]
Restricted stock units [Member]	'		'		'		'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'		'		'		'
Restricted stock units granted	'		'		3,387,079		'
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]	'		'		'		'
Restricted stock units granted, weighted average grant date fair value (per share)	$29.57		$29.48		$26.31		$25.08
ESP Plan [Member]	'		'		'		'
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]	'		'		'		'
Expected holding period (in years)	'6 months		'6 months		'6 months		'6 months
Risk-free interest rate	0.10%		0.10%		0.10%		0.10%
Expected stock price volatility	21.70%		26.10%		21.70%		26.10%
Dividend yield	3.70%		3.60%		3.70%		3.60%
Volterra [Member] | Stock Option [Member]	'		'		'		'
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]	'		'		'		'
Options granted, weighted average fair value of stock options (per share)	'		'		$10.56		'
Volterra [Member] | Stock options [Member]	'		'		'		'
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]	'		'		'		'
Expected holding period (in years)	'3 years 9 months 18 days	[1]	'		'		'
Risk-free interest rate	1.00%	[1]	'		'		'
Expected stock price volatility	27.50%	[1]	'		'		'
Dividend yield	3.40%	[1]	'		'		'
Volterra [Member] | Restricted stock units [Member]	'		'		'		'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'		'		'		'
Restricted stock units granted	'		'		418,955		'
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]	'		'		'		'
Restricted stock units granted, weighted average grant date fair value (per share)	'		'		$29.53		'
[1]	Table excludes impact from assumptions used in valuing the Volterra substitute options granted on October 1, 2013 based on an expected holding period of 3.8 years, risk-free interest rate of 1.0%, expected stock price volatility of 27.5% and dividend yield of 3.4%.

StockBased_Compensation_Stock_

Stock-Based Compensation, Stock Option Plans (Details) (USD $)	3 Months Ended				9 Months Ended
	Mar. 29, 2014		Mar. 30, 2013		Mar. 29, 2014		Mar. 30, 2013
Stock options [Member]	'		'		'		'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'		'		'		'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'4 years 10 months 24 days	[1]	'4 years 10 months 24 days	[1]	'5 years 3 months 18 days	[1]	'5 years 3 months 18 days	[1]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'		'		'		'
Options outstanding, beginning	'		'		20,081,339		'
Options Granted	'		'		2,882,740		'
Options Exercised	'		'		-2,267,719		'
Options Cancelled	'		'		-3,042,128		'
Options outstanding, ending	18,327,417		'		18,327,417		'
Options outstanding, weighted average exercise price, beginning (per share)	'		'		$26		'
Options granted, weighted average exercise price (per share)	'		'		$27.17		'
Options exercised, weighted average exercise price (per share)	'		'		$18.07		'
Options cancelled, weighted average exercise price (per share)	'		'		$32.25		'
Options outstanding, weighted average exercise price, ending (per share)	$26.04		'		$26.04		'
Options outstanding, weighted average remaining contractual term (in years)	'		'		'3 years 7 months 6 days		'
Options outstanding, aggregate intrinsic value	$148,116,516	[2]	'		$148,116,516	[2]	'
Options exercisable, number of shares	8,592,118		'		8,592,118		'
Options exercisable, weighted average exercise price (per share)	$27.62		'		$27.62		'
Options exercisable, weighted average remaining contractual term (in years)	'		'		'1 year 10 months 24 days		'
Options exercisable, aggregate intrinsic value	69,970,388	[2]	'		69,970,388	[2]	'
Options vested and expected to vest, number of shares	17,245,995		'		17,245,995		'
Options vested and expected to vest, weighted average exercise price (per share)	$26.01		'		$26.01		'
Options vested and expected to vest, weighted average remaining contractual term (in years)	'		'		'3 years 6 months		'
Options vested and expected to vest, aggregate intrinsic value	141,248,804	[2]	'		141,248,804	[2]	'
Unrecognized compensation costs related to unvested stock options	$40,700,000		$35,300,000		$40,700,000		$35,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares	9,700,000		10,200,000		9,700,000		10,200,000
Weighted average period of recognition for unrecognized compensation costs (in years)	'2 years 9 months 18 days		'		'		'2 years 9 months 18 days
Risk-free interest rate	1.60%	[1]	0.80%		1.40%	[1]	0.70%	[1]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	30.20%	[1]	37.50%		34.80%	[1]	37.80%	[1]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	3.60%	[1]	3.40%		3.20%	[1]	3.30%	[1]
Stock Option [Member]	'		'		'		'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'		'		'		'
Options granted, weighted average fair value of stock options (per share)	$5.55		$7.39		$7.39		$6.69
Volterra [Member] | Stock options [Member]	'		'		'		'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'		'		'		'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'3 years 9 months 18 days	[1]	'		'		'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'		'		'		'
Options Granted	'		'		673,185		'
Options granted, weighted average exercise price (per share)	'		'		$22.26		'
Risk-free interest rate	1.00%	[1]	'		'		'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	27.50%	[1]	'		'		'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	3.40%	[1]	'		'		'
Volterra [Member] | Stock Option [Member]	'		'		'		'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'		'		'		'
Options granted, weighted average fair value of stock options (per share)	'		'		$10.56		'
[1]	Table excludes impact from assumptions used in valuing the Volterra substitute options granted on October 1, 2013 based on an expected holding period of 3.8 years, risk-free interest rate of 1.0%, expected stock price volatility of 27.5% and dividend yield of 3.4%.
[2]	(1)Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Companybs common stock on March 28, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 29, 2014.

StockBased_Compensation_Restri

Stock-Based Compensation, Restricted Stock Units (Details) (Restricted stock units [Member], USD $)	3 Months Ended			9 Months Ended
	Mar. 29, 2014		Mar. 30, 2013	Mar. 29, 2014
Outstanding and expected to vest RSUs [Roll Forward]	'		'	'
Restricted stock units outstanding, beginning	'		'	7,965,532
Restricted stock units granted	'		'	3,387,079
Restricted stock units released	'		'	-2,141,883
Restricted stock units cancelled	'		'	-903,922
Restricted stock units outstanding, ending	8,725,761		'	8,725,761
Restricted stock units outstanding, weighted average remaining contractual term (in years)	'		'	'2 years 8 months 12 days
Restricted stock units outstanding, aggregate intrinsic value	$284,624,813	[1]	'	$284,624,813	[1]
Restricted stock units expected to vest, number of shares	7,626,649		'	7,626,649
Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other than Options, Expected to Vest, Weighted Average Remaining Contractual Term 1	'		'	'2 years 8 months 12 days
Restricted stock units expected to vest, aggregate intrinsic value	249,086,361	[1]	'	249,086,361	[1]
Value of restricted stock unit shares withheld for withholding tax	8,400,000		'	22,500,000
Unrecognized compensation costs related to unvested RSUs	$146,300,000		$127,600,000	$146,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares	8,700,000		8,700,000	8,700,000
Weighted average period of recognition for unrecognized compensation costs (in years)	'2 years 8 months 12 days		'2 years 8 months 12 days	'
Volterra [Member]	'		'	'
Outstanding and expected to vest RSUs [Roll Forward]	'		'	'
Restricted stock units granted	'		'	418,955
[1]	(1)Aggregate intrinsic value for RSUs represents the closing price per share of the Companybs common stock on March 28, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 29, 2014.

StockBased_Compensation_Employ

Stock-Based Compensation, Employee Stock Purchase Plan (Details) (ESP Plan [Member], USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
ESP Plan [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'6 months	'6 months	'6 months	'6 months
Risk-free interest rate	0.10%	0.10%	0.10%	0.10%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	21.70%	26.10%	21.70%	26.10%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	3.70%	3.60%	3.70%	3.60%
Unrecognized compensation expense	$4.90	'	$4.90	'

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Numerator for basic earnings per share and diluted earnings per share	'	'	'	'
Net income	$122,544	$131,388	$270,017	$335,898
Denominator for basic earnings per share	282,627,000	292,888,000	283,315,000	292,048,000
Effect of dilutive securities	'	'	'	'
Stock options, ESPP and RSUs	5,948,000	7,194,000	5,807,000	6,773,000
Denominator for diluted earnings per share	288,575,000	300,082,000	289,122,000	298,821,000
Income (Loss) from Continuing Operations, Per Basic Share	$0.43	$0.44	$0.95	$1.14
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	$0	$0.01	$0	$0.01
Earnings per share, Basic (per share)	$0.43	$0.45	$0.95	$1.15
Income (Loss) from Continuing Operations, Per Diluted Share	$0.42	$0.43	$0.93	$1.11
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	$0	$0.01	$0	$0.01
Earnings per share, Diluted (per share)	$0.42	$0.44	$0.93	$1.12
Antidilutive securities excluded from computation of earnings per share	9,800,000	9,000,000	9,800,000	10,600,000

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013	Jun. 29, 2013
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenues	$605,681	$604,884	$1,811,196	$1,833,265	'
Long-lived assets	1,355,268	'	1,355,268	'	1,373,124
United States [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenues	68,944	63,784	241,082	185,765	'
Long-lived assets	1,057,881	'	1,057,881	'	1,058,579
China [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenues	240,677	225,808	745,886	767,192	'
Korea [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenues	33,217	73,362	101,979	194,357	'
Rest of Asia [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenues	160,703	151,231	444,270	425,904	'
Europe [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenues	84,005	75,734	230,032	213,582	'
Rest of World [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenues	18,135	14,965	47,947	46,465	'
Long-lived assets	121,751	'	121,751	'	130,874
Philippines [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Long-lived assets	$175,636	'	$175,636	'	$183,671

Comprehensive_Income_Accumulat

Comprehensive Income Accumulated Other Comprehensive Income (Loss) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	'	'	($15,747)	'
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	-501	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	'	'	2,601	'
Other Comprehensive Income (Loss), Tax	'	'	1,341	'
Other Comprehensive Income (Loss), Net of Tax	263	-2,175	3,441	-2,188
Accumulated Other Comprehensive Income (Loss), Net of Tax	-12,306	'	-12,306	'
Unrealized Holding Gains (Losses) on Intercompany Receivables [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	'	'	-7,401	'
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	0	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	'	'	0	'
Other Comprehensive Income (Loss), Tax	'	'	1,742	'
Other Comprehensive Income (Loss), Net of Tax	'	'	1,742	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	-5,659	'	-5,659	'
Accumulated Defined Benefit Plans Adjustment [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	'	'	-5,838	'
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	0	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	'	'	1,076	'
Other Comprehensive Income (Loss), Tax	'	'	-224	'
Other Comprehensive Income (Loss), Net of Tax	'	'	852	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	-4,986	'	-4,986	'
Accumulated Translation Adjustment [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	'	'	-1,527	'
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	0	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	'	'	0	'
Other Comprehensive Income (Loss), Tax	'	'	0	'
Other Comprehensive Income (Loss), Net of Tax	'	'	0	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	-1,527	'	-1,527	'
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	'	'	-1,004	'
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	-465	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	'	'	1,525	'
Other Comprehensive Income (Loss), Tax	'	'	-190	'
Other Comprehensive Income (Loss), Net of Tax	'	'	870	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	-134	'	-134	'
Unrealized Holding Gains (losses) on Available-for-sale Investments [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	'	'	23	'
Other Comprehensive Income (Loss), before Reclassifications, before Tax	'	'	-36	'
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	'	'	0	'
Other Comprehensive Income (Loss), Tax	'	'	13	'
Other Comprehensive Income (Loss), Net of Tax	'	'	-23	'
Accumulated Other Comprehensive Income (Loss), Net of Tax	$0	'	$0	'

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Provision for income taxes	($10,632,000)	$22,824,000	$31,602,000	$92,725,000
Discontinued Operation, Tax Effect of Discontinued Operation	'	'	'	700,000
Effective Income Tax Rate Reconciliation, Percent	-9.50%	15.10%	10.50%	21.80%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate	35.00%	'	'	'
Effective Income Tax Rate Reconciliation, Tax Credit, Amount	'	'	34,600,000	'
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	'	'	'	7,100,000
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount	'	'	'	21,400,000
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities	'	'	$26,000,000	'

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	3 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Dec. 28, 2013	Mar. 29, 2014
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]	'	'
Product Warranty Accrual	'	$3,075
Product Warranty Accrual, Additions from Business Acquisition	13,911	'
Product Warranty Accrual, Warranties Issued	18,100	19,640
Product Warranty Accrual, Payments	'	-12,776
Product Warranty Accrual, Preexisting, Increase (Decrease)	'	187
Product Warranty Accrual	'	$24,037

Common_Stock_Repurchases_Detai

Common Stock Repurchases (Details) (USD $)	1 Months Ended	9 Months Ended
Share data in Millions, unless otherwise specified	Jul. 31, 2013	Mar. 29, 2014
Common Stock Repurchases [Abstract]	'	'
Stock repurchase program, authorized amount	$1,000,000,000	'
Shares of common stock repurchased	'	9.2
Value of common stock repurchased	'	264,600,000
Stock repurchase program, remaining authorized amount	'	$802,600,000

Acquisitions_Details

Acquisitions (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

6 Months Ended

9 Months Ended

In Thousands, except Per Share data, unless otherwise specified

Mar. 29, 2014

Mar. 30, 2013

Mar. 29, 2014

Mar. 30, 2013

Jun. 29, 2013

Mar. 29, 2014

Dec. 28, 2013

Mar. 29, 2014

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Mar. 29, 2014

acquisitions

Volterra [Member]

Volterra [Member]

Volterra [Member]

Volterra [Member]

Volterra [Member]

Volterra [Member]

Volterra [Member]

Volterra [Member]

Other Acquisition [Member]

Intellectual property [Member]

Customer relationships [Member]

Tradename [Member]

Order or Production Backlog [Member]

Patents [Member]

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Effective Date of Acquisition

'

'

'

'

'

1-Oct-13

'

'

'

'

'

'

'

'

Business Acquisition, Percentage of Voting Interests Acquired

100.00%

'

100.00%

'

'

'

'

'

'

'

'

'

'

'

Business Acquisition, Share Price

$23

'

$23

'

'

'

'

'

'

'

'

'

'

'

Payments to Acquire Businesses, Gross

'

'

'

'

'

'

$593,250

'

'

'

'

'

'

'

Business Acquisition, Cash Paid for Employee's Vested Options

'

'

'

'

'

'

21,756

'

'

'

'

'

'

'

Business Combination, Consideration Transferred

'

'

'

'

'

'

615,006

'

'

'

'

'

'

6,100

Business Combination, Acquisition Related Costs

-88

0

6,983

0

'

'

'

7,000

'

'

'

'

'

'

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

'

'

'

'

'

'

'

'

'4 years 10 months 24 days

'9 years 7 months 6 days

'4 years

'4 months 24 days

'4 years 9 months 18 days

'

Number of Businesses Acquired

'

'

2

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Business Combination, Cash and Equivalents

'

'

'

'

'

'

163,500

'

'

'

'

'

'

'

Business Combination, Receivables

'

'

'

'

'

'

23,453

'

'

'

'

'

'

'

Business Combination, Inventory

'

'

'

'

'

'

33,339

'

'

'

'

'

'

'

Business Combination, Other Noncurrent Assets

'

'

'

'

'

'

17,151

'

'

'

'

'

'

'

Business Combination, Accrued Liabilities

'

'

'

'

'

'

-35,343

'

'

'

'

'

'

'

Business Combination, Income Tax Payable

'

'

'

'

'

'

-23,241

'

'

'

'

'

'

'

Business Combination, Current Liabilities, Other

'

'

'

'

'

'

-20,149

'

'

'

'

'

'

'

Business Combination, Assets Acquired and Liabilities Assumed, Net

'

'

'

'

'

'

158,710

'

'

'

'

'

'

'

Business Combination, Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles

'

'

'

'

'

'

226,900

'

192,500

24,600

6,400

900

2,500

'

Business Combination, Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets

'

'

'

'

'

'

56,200

'

'

'

'

'

'

'

Goodwill

597,676

'

597,676

'

422,004

'

174,894

'

'

'

'

'

'

'

Business Combination, Consideration Transferred, Equity Interests Issued and Issuable

'

'

'

'

'

'

-1,698

'

'

'

'

'

'

'

Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net

'

'

'

'

'

'

$615,006

'

'

'

'

'

'

'

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets, Goodwill (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Jun. 29, 2013
Goodwill [Roll Forward]	'	'
Goodwill	'	$422,004
Goodwill, Acquired During Period	175,493	'
Goodwill, Translation and Purchase Accounting Adjustments	179	'
Goodwill	$597,676	$422,004

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets Useful Lives of Amortizable Intangible Assets (Details)	9 Months Ended
	Mar. 29, 2014
Intellectual property [Member] | Minimum [Member]	'
Amortizable intangible assets, useful life, minimum (in years)	'3 months
Intellectual property [Member] | Maximum [Member]	'
Amortizable intangible assets, useful life, minimum (in years)	'10 years
Customer relationships [Member] | Minimum [Member]	'
Amortizable intangible assets, useful life, minimum (in years)	'5 years
Customer relationships [Member] | Maximum [Member]	'
Amortizable intangible assets, useful life, minimum (in years)	'10 years
Tradename [Member] | Minimum [Member]	'
Amortizable intangible assets, useful life, minimum (in years)	'3 years
Tradename [Member] | Maximum [Member]	'
Amortizable intangible assets, useful life, minimum (in years)	'4 years
Order or Production Backlog [Member]	'
Amortizable intangible assets, useful life, minimum (in years)	'4 months
Patents [Member]	'
Amortizable intangible assets, useful life, minimum (in years)	'5 years

Goodwill_and_Intangible_Assets4

Goodwill and Intangible Assets, Intangible Assets (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013	Jun. 29, 2013
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'	'	'	'	'
Original Cost	$568,192	'	$568,192	'	$327,892
Accumulated Amortization	252,127	'	252,127	'	193,128
IPR&D	68,102	'	68,102	'	22,382
Gross Intangible Assets	636,294	'	636,294	'	350,274
Total purchased intangible assets	384,167	'	384,167	'	157,146
Cost of goods sold, amortization	18,542	7,777	45,732	26,217	'
Operating Expenses, Amortization	4,863	3,903	13,267	11,855	'
Amortization of Intangible Assets	23,405	11,680	58,999	38,072	'
Future amortization expense [Abstract]	'	'	'	'	'
Remaining three months of 2014	23,172	'	23,172	'	'
2015	90,443	'	90,443	'	'
2016	74,454	'	74,454	'	'
2017	61,782	'	61,782	'	'
2018	41,927	'	41,927	'	'
2019	13,278	'	13,278	'	'
Thereafter	11,009	'	11,009	'	'
Net	316,065	'	316,065	'	134,764
Intellectual property [Member]	'	'	'	'	'
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'	'	'	'	'
Original Cost	435,962	'	435,962	'	230,562
Accumulated Amortization	182,773	'	182,773	'	136,870
Future amortization expense [Abstract]	'	'	'	'	'
Net	253,189	'	253,189	'	93,692
Intellectual property [Member] | Minimum [Member]	'	'	'	'	'
Finite and Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortizable intangible assets, useful life, minimum (in years)	'	'	'3 months	'	'
Intellectual property [Member] | Maximum [Member]	'	'	'	'	'
Finite and Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortizable intangible assets, useful life, minimum (in years)	'	'	'10 years	'	'
Customer relationships [Member]	'	'	'	'	'
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'	'	'	'	'
Original Cost	120,230	'	120,230	'	95,230
Accumulated Amortization	65,262	'	65,262	'	54,308
Future amortization expense [Abstract]	'	'	'	'	'
Net	54,968	'	54,968	'	40,922
Customer relationships [Member] | Minimum [Member]	'	'	'	'	'
Finite and Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortizable intangible assets, useful life, minimum (in years)	'	'	'5 years	'	'
Customer relationships [Member] | Maximum [Member]	'	'	'	'	'
Finite and Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortizable intangible assets, useful life, minimum (in years)	'	'	'10 years	'	'
Tradename [Member]	'	'	'	'	'
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'	'	'	'	'
Original Cost	8,500	'	8,500	'	2,100
Accumulated Amortization	2,836	'	2,836	'	1,950
Future amortization expense [Abstract]	'	'	'	'	'
Net	5,664	'	5,664	'	150
Tradename [Member] | Minimum [Member]	'	'	'	'	'
Finite and Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortizable intangible assets, useful life, minimum (in years)	'	'	'3 years	'	'
Tradename [Member] | Maximum [Member]	'	'	'	'	'
Finite and Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortizable intangible assets, useful life, minimum (in years)	'	'	'4 years	'	'
Order or Production Backlog [Member]	'	'	'	'	'
Finite and Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortizable intangible assets, useful life, minimum (in years)	'	'	'4 months	'	'
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'	'	'	'	'
Original Cost	1,000	'	1,000	'	0
Accumulated Amortization	1,000	'	1,000	'	0
Future amortization expense [Abstract]	'	'	'	'	'
Net	0	'	0	'	0
Patents [Member]	'	'	'	'	'
Finite and Indefinite Lived Intangible Assets [Line Items]	'	'	'	'	'
Amortizable intangible assets, useful life, minimum (in years)	'	'	'5 years	'	'
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'	'	'	'	'
Original Cost	2,500	'	2,500	'	0
Accumulated Amortization	256	'	256	'	0
Future amortization expense [Abstract]	'	'	'	'	'
Net	2,244	'	2,244	'	0
In Process Research and Development [Member]	'	'	'	'	'
Intangible Assets, Net (Excluding Goodwill) [Abstract]	'	'	'	'	'
IPR&D	$68,102	'	$68,102	'	$22,382

Impairment_of_LongLived_Assets1

Impairment of Long-Lived Assets (Details) (USD $)	3 Months Ended					9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Dec. 28, 2013	Mar. 30, 2013	Dec. 29, 2012	Sep. 29, 2012	Mar. 29, 2014	Mar. 30, 2013
impairment of long life assets [Abstract]	'	'	'	'	'	'	'
Impairment of Long-Lived Assets to be Disposed of	$0	$5,197	$0	$22,222	$2,700	$5,197	$24,929

Restructuring_Activities_Detai

Restructuring Activities (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Severance and restructuring expenses	$3,338	$151	$19,112	$2,387
Volterra Restructuring Plan [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Severance and restructuring expenses	'	'	10,600	'
Business Unit Reorganization [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Severance and restructuring expenses	'	'	$8,500	'